<bill session="111" type="s" number="641" updated="2014-12-10T13:54:23-05:00">
  <state datetime="2009-03-19">REFERRED</state>
  <status>
    <introduced datetime="2009-03-19"/>
  </status>
  <introduced datetime="2009-03-19"/>
  <titles>
    <title type="short" as="introduced">Dehydroepiandrosterone Abuse Reduction Act of 2009</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to prevent the abuse of dehydroepiandrosterone, and for other purposes.</title>
  </titles>
  <sponsor id="300048"/>
  <cosponsors/>
  <actions>
    <action datetime="2009-03-19">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3553-3554"/>
    </action>
    <action datetime="2009-03-19" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Athletes"/>
    <term name="Child health"/>
    <term name="Department of Justice"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Internet and video services"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary>3/19/2009--Introduced.
Dehydroepiandrosterone Abuse Reduction Act of 2009- Amends the Controlled Substances Act to impose civil penalties for knowingly selling, causing another to sell, or conspiring to sell a product containing dehydroepiandrosterone to an individual under the age of 18 years, including any such sale using the Internet.</summary>
</bill>
